Journal
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA
Volume 23, Issue 2, Pages 265-+Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.soc.2013.11.001
Keywords
Distal cholangiocarcinoma; Nodal dissection; Neoadjuvant therapy; Surgical resection
Funding
- Ann & Paul Hastings Scholarship for Excellence in Surgical Oncology and Patient Care
Ask authors/readers for more resources
Distal cholangiocarcinoma is an uncommon malignancy and early diagnosis remains a challenge. More accurate diagnostic modalities for early-stage diagnosis are needed. Advances in medical therapy and neoadjuvant treatment may aid surgery and further improve postoperative outcomes. Margin-negative resection in conjunction with thorough nodal dissection is the strongest prognostic factor. Surgical resection coupled with adjuvant therapy provides the most favorable outcome. Future efforts should be aimed at reducing surgical complications and improving medical therapy, leading to overall improvement in perioperative and long-term outcomes for patients with this disorder.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available